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Abstract 
Background. Auditory external cues enhance step initiation in Parkinson's disease (PD) patients. We wanted to 
explore whether a startle reaction has a comparable effect on step initiation in PD. 
Methods. Thirteen PD patients and 13 aged-matched controls participated in this study. Electromyography pattern 
and onset toe-off time during a step initiation task were recorded in response to three different stimuli: a visual 
imperative stimulus; visual stimulus simultaneous with a nonstartle auditory stimulus and with a startle auditory 
stimulus. 
Results. In all subjects, onset of tibialis anterior was faster in the startle auditory condition, compared with the 
nonstartle auditory condition. However, in the patient group, there was no difference in onset of soleus and toe-off 
between the startle and nonstartle conditions. 
Conclusions. Startle reaction in PD patients demonstrates a disordered coupling between the anticipatory postural 
adjustments that initiate the weight shift and the movement to initiate toe-off during step initiation. 
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Step initiation is often impaired in Parkinson's disease (PD) as a result of abnormalities of the motor 
program responsible for the anticipatory postural adjustments (APAs).1 Recently, the startle reaction 
effect has been tested for step initiation, and results show that startle stimuli triggered APA in PD faster 
than during a nonstartle condition.2 However, facilitation of gait initiation in PD patients occurs also with 
nonstartle external cues.3, 4 This facilitated reaction to a cue applied with another simultaneous stimulus 
is known as intersensory facilitation5 and may explain effects observed with startle, in some experimental 
conditions.6 We undertook this study to investigate whether the latency shortening induced in step 
initiation by the simultaneous delivery of a startling stimulus has a similar degree and characteristics as 
the one induced by a nonstartling external cue in PD patients. 
Subjects and Methods 
Thirteen subjects diagnosed with PD (mean age: 56 ± 13 years; Table 1) and 13 age-matched healthy 
subjects (mean age: 53 ± 11) with no history of neurologic disease were included in this study. No subject 
showed dementia, as assessed by the Mini–Mental State Examination (MMSE). All tests were carried out 
while the patients were ON medication. The study was approved by the local ethics committee. All 
participants provided informed consent. 
  
Table 1. Details of PD patient characteristics 
Patient 
No. 
Age 
(Years) 
Sex 
Disease 
Duration 
(Years) 
Type H & Y UPDRS Motor Medication Per Day (mg) 
1 67 Male 3 M 2 15 
Levodopa/benserazide 500/125, rasagiline 1, 
pramipexole 2.64 
2 37 Male 2 M 1 9 Rasagiline 1 
3 66 Female 12 T 2.5 12 
Levodopa/carbidopa 200/50, levodopa/benserazide 
550/137.5, rotigotine 6, Rasagiline 1, amantadine 200 
4 79 Female 7 AR 3 35 Levodopa/carbidopa 400/50, pramipexole 0.18 
5 58 Male 6 M 2 23 Levodopa/carbidopa 500/125, rasagiline 1, rotigotine 4 
6 60 Male 6 A 2 12 
Levodopa/carbidopa 800/200, entacapone 800, 
pramipexole 3.15 
7 60 Male 7 M 2 13 
Levodopa/carbidopa 500/125, ropinirole 12, 
trihexyphenidyl 2 
8 62 Female 2 AR 3 31 
Levodopa/carbidopa 600/150, entacapone 600, rotigotine 
6, pramipexole 3.15 
9 68 Male 1 AR 2.5 16 
Levodopa/carbidopa 150/37.5, entacapone 600, 
rasagiline 1 
10 50 Male 5 AR 2 19 Levodopa/carbidopa 300/75, rasagiline 1, rotigotine 8 
11 39 Female 1 T 2 18 
Levodopa/carbidopa 375/93.75, entacapone 600, 
rasagiline 1 
12 45 Male 3 M 2 11 
Levodopa/carbidopa 225/56.25, entacapone 600, 
rasagiline 1, rotigotine 4 
13 40 Female 1 M 1 4 Levodopa/carbidopa 300/75, rasagiline 1, rotigotine 6 
  
      
  
Mean 56 
 
4.3 
 
2 16.76   
SD 13 
 
3.25 
 
0.63 8.6   
        
 
Abbreviations: AR, akinetic-rigid; T, tremor-dominant; M, mixed; SD, standard deviation. 
Procedure 
Subjects were requested to maintain a stationary standing posture over two contact platforms (Bosco 
system). They were instructed to perform a rapid initiation of gait with their right leg in response to a 
visual imperative stimulus (IS) and keep walking until they completed three consecutive steps. The IS 
was a white 25-cm
2
 square displayed on a black computer screen situated in front of the subject. A 
warning auditory cue preceded the IS with a variable period of 3 to 5 seconds. In some trials, the onset of 
the IS was simultaneous with an auditory stimulus, a 750-Hz tone burst lasting 30 ms. The intensity of the 
auditory stimulus was set either low (80 dB = LAS) or high enough to induce a startling reaction (130 dB 
= SAS). The session consisted of one block of 25 trials: 15 trials consisted of only the IS (IS condition), 
five trials contained IS and LAS (LAS condition), and five trials contained IS and SAS (SAS condition). 
The order of the trials was randomized with a minimum intertrial interval of 10 seconds. 
Data Analysis 
Electromyographic (EMG) activity was recorded from the following muscles: tibialis anterior (TA); 
soleus (SOL); and rectus femoris (RF) of the right limb for the gait initiation session. EMG was recorded 
with pairs of surface silver/silver chloride electrodes (0.7 cm in diameter). EMG from the right and left 
sternocleidomastoids (SCMs) was recorded during the practice trials to ensure that the startle reflex 
indeed occurred only when delivering a SAS. Raw EMG signals were amplified and filtered with a band-
pass filter of 30 Hz to 1 kHz (Digitimer Ltd., Welwyn Garden City, UK). Signals were digitized at 2 kHz 
(CED Power1401; Cambridge Electronic Design, Cambridge, UK) and stored for off-line analysis. 
Onset and offset latencies of EMG activity were visually determined using an interactive cursor of 1-
ms resolution in combination with a Teager-Kaiser energy operator (TKEO) method.7 Onset toe-off for 
step initiation was measured as the time between the imperative stimulus and toe-off in the right foot. 
Statistical Analysis 
Repeated-measures analysis of variance (ANOVA) was performed with condition (IS, IS+LAS, and 
IS+SAS) and group (control and PD) for the following variables: onset latency and duration of SOL, TA, 
and RF EMG bursts and of soleus inhibition (SOLin). A post-hoc analysis (least significant difference) 
was carried out whenever differences were detected with ANOVA. Latency differences were calculated 
between TA and SOL (time TA-SOL). A P value ≤0.05 was considered statistically significant. 
Results 
In the PD group, SOL inhibition was excluded from the analysis because it was not measurable in 9 of 
13 of the patients, in whom no consistent SOL tonic activity was observed during standing (Fig. 1). 
 
 
 
Figure 1. (A) Schematic representation of the mean EMG pattern in the gait initiation task in controls and PD patients across 
conditions. (IS) imperative visual stimulus; (IS+AS) visual plus auditory stimulus; (IS+SS) visual plus startle auditory stimulu; (RT) 
reaction time for toe-off; (SOLin) soleus inhibition; (SOL) soleus burst; (TA) tibialisis anterior burst; (RF) recto femoris burst. 
Except SOLin, the leftward extent of the bars represents the mean onset latency, whereas the horizontal line shows +1 EM. Length 
of the bars represents the duration of the EMG bursts, and the horizontal lines at the right side of the bar show +1 EM. Note: (1) the 
absence of SOLin in the PD group and (2) the significant delay between the onset TA and SOL for the IS+SS condition in PD 
groups, in comparison with the other conditions. (B) Reaction times for the step initiation task across conditions. *Significant 
differences between conditions (P < 0.05); #between groups (P < 0.05). 
The ANOVA showed a main effect of condition on onset latency of TA (P < 0.0001) and RF (P < 
0.0001), with no significant group interactions or group effect (Table 2; Fig. 1A). For both muscles, onset 
latency was slower in the IS condition, compared with the LAS condition (P = 0.001 and P < 0.0001 for 
TA and RF, respectively) and SAS condition (P < 0.0001 for both muscles). In addition, onset latency for 
the SAS condition was significantly faster than for the LAS condition (P = 0.002 and P = 0.001 for TA 
and RF, respectively). The ANOVA for the onset latency of SOL showed significant effects of condition 
(P = 0.002), group (P = 0.003), and a condition*group interaction (P = 0.002). Both groups showed a 
significantly faster SOL onset latency in the LAS condition, in comparison with the IS condition (P = 
0.028 and P = 0.04 for PD and control group, respectively). Although the SOL onset latency was 
significantly faster for the SAS condition than for the LAS and IS conditions in the control group (P < 
0.005 in both comparisons), differences were not significant for the PD group between SAS and IS 
conditions (P = 0.31) or between SAS and LAS conditions (P = 0.5). In addition, ANOVA showed a 
significant condition*group interaction for the TA-SOL time difference (P = 0.018) and a significant 
overall group effect (P = 0.004). Post-hoc analysis revealed that the TAL-SOL time difference in patients 
were significantly longer than in control subjects for all conditions (P < 0.04 for IS and LAS; P < 0.01 for 
SAS). In the PD group, the TA-SOL time difference was significantly longer in the SAS condition than in 
the IS condition (P = 0.048), whereas no significant differences were found between these conditions in 
the control group. 
Table 2. Onset latency and duration of EMG bursts 
Condition IS  LAS  SAS 
Parameters/Group PD Control  PD Control  PD Control 
         
Step initiation 
  
 
  
 
  
 Time to toe-off 850 ± 38 677 ± 33  797 ± 32 628 ± 36  780 ± 42 546 ± 51 
 Onset TA 318 ± 105 262 ± 71  220 ± 51 196 ± 54  118 ± 42 105 ± 23 
 Duration TA 192 ± 85 203 ± 61  166 ± 64 167 ± 37  158 ± 77 145 ± 64 
 Onset SOLin — 238 ± 96  — 170 ± 67  — 71 ± 19 
 Duration SOLin — 43 ± 20  — 37 ± 32  — 29 ± 8 
 Onset SOL 554 ± 116 380 ± 136  416 ± 111 319 ± 127  485 ± 163 208 ± 102 
 Duration SOL 128 ± 51 122 ± 25  124 ± 45 124 ± 42  104 ± 39 94 ± 26 
 Time TA-SOL 236 ± 129 153 ± 106  247 ±93 130 ± 94  311 ± 199 112 ± 82 
 Onset RF 336 ± 102 274 ± 52  218 ± 62 202 ± 76  105 ± 45 100 ± 65 
 Duration RF 155 ± 65 144 ± 76  138 ± 67 134 ± 73  127 ± 42 120 ± 53 
         
 
The ANOVA for the onset of toe-off showed a significant main effect for condition (P < 0.0001) and 
a significant condition*group interaction (P = 0.035) (Fig. 1B). Onset of toe-off was significantly slower 
in PD patients than in controls (P < 0.01 for all comparisons). Both groups showed a significant, but mild, 
shortening of onset of toe-off in the LAS condition (∼6%), in comparison with the IS condition (P < 
0.0001). In the SAS condition, only the control group demonstrated a further decrease in onset toe-off 
(∼14%), in comparison with the LAS condition (P < 0.005). In PD patients, the onset toe-off was 
significantly faster in the SAS condition than in the IS condition (P < 0.005). However, unlike the 
controls, there were no significant differences in onset toe-off between SAS and LAS conditions. 
Discussion 
During the IS condition, EMG analysis of the step initiation showed a heterogeneous pattern across 
the PD patients. The timing between tibialis and soleus activation in patients was longer than in control 
subjects, suggesting an impaired coordination between the postural phase and step initiation. Similar 
findings have been reported in previous studies.1, 2, 8–10 These abnormalities in EMG pattern can 
explain the longer onset toe-off of the step initiation in patients, compared to the control group. Our 
findings are in contrast to those of other studies reporting improved gait initiation in PD on medication.3 
For instance, Burgleih-Jacobs et al.3 did not find differences in the push-off phase during a cued step task 
between PD on and control subjects. However, they showed that the push-off duration in the PD group 
(on or off) was still longer than controls. Rocchi et al.11 reported an improvement of APA between off 
and on condition, but this effect was affected by the initial stance position. In fact, with a wide stance, the 
patients in on had a significantly longer APA than control subjects. Thus, it seems that more variables 
than medication can affect gait initiation in PD patients. 
When a nonstartling auditory stimulus was presented simultaneously with the IS, our PD patients were 
able to speed up the onset of both tibialis and soleus activations, in comparison with the single 
presentation of the IS. This observation has been reported on before.3, 4 The mechanism underlying this 
effect remains unclear, although nondopaminergic pathways, such as the cerebello-thalamocortical 
pathways, have been implicated.12 
The tibialis and soleus onset activations were ealier for the startle, compared with a nonstartling, 
stimulus in the control group. However, this additional beneficial effect of the startling stimulus was only 
present for the tibialis, but not for the soleus, in the PD group. In line with a recent study with PD patients 
in off-medication state,2 PD patients showed an earlier onset of the tibialis anterior muscle EMG activity 
in the startling, compared with the nonstartling, condition, suggesting that patients were able to prepare 
the anticipatory postural adjustments before an expected cue to initiate gait. However, our study suggests 
that this earlier tibialis activation did not translate into a faster toe-off. One possible explanation may be 
that the SOL activation at the end of the postural phase, which contributes to the lifting of the foot, was 
significantly delayed. This may be related to the impaired modulation of the soleus H-reflex that has been 
described in PD patients using auditory stimuli13 or transcranial magnetic stimulation.14 As a result of 
the long time period between the onset of tibialis activity and toe-off, we cannot exclude other afferent 
and efferent pathways that could explain this delay rather than the specific gait initiation pathway. 
Conclusions 
In summary, our results show that a startle stimulus during a gait initiation task leads to an earlier 
onset of tibialis anterior activity, although the timing of toe-off of the stepping leg was not significantly 
changed. This is of relevance, because it suggests that there is a disordered coupling between the APA 
that initiates the weight shift and the movement to initiate toe-off. 
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